serine has been researched along with ALS - Amyotrophic Lateral Sclerosis in 48 studies
Serine: A non-essential amino acid occurring in natural form as the L-isomer. It is synthesized from GLYCINE or THREONINE. It is involved in the biosynthesis of PURINES; PYRIMIDINES; and other amino acids.
serine : An alpha-amino acid that is alanine substituted at position 3 by a hydroxy group.
Excerpt | Relevance | Reference |
---|---|---|
"Impaired enzymatic activity in D-amino acid oxidase (DAAO) caused by missense mutations has been shown to trigger amyotrophic lateral sclerosis (ALS) through an abnormal accumulation of D-serine in the spinal cord." | 3.96 | Mechanistic insights into the loss-of-function mechanisms of rare human D-amino acid oxidase variants implicated in amyotrophic lateral sclerosis. ( Padhi, AK; Zhang, KYJ, 2020) |
"The substitution of Proline with Serine at residue 56 (P56S) of vesicle-associated membrane protein-associated protein B (VAPB) has been linked to an atypical autosomal dominant form of familial amyotrophic lateral sclerosis 8 (ALS8)." | 3.79 | Amyotrophic lateral sclerosis-related VAPB P56S mutation differentially affects the function and survival of corticospinal and spinal motor neurons. ( Aliaga, L; Cai, H; Chub, N; Lai, C; Lin, X; O'Donovan, MJ; Shim, H; Sun, L; Xie, C; Yang, WJ; Yu, J, 2013) |
"Hydroxyl radical, ascorbate free radical, superoxide dismutase (SOD) activities, Cu,Zn-SOD protein, Mn-SOD protein, 8-hydroxy-2' -deoxyguanosine (8-OHdG) and metals were compared in red blood cells (RBC), plasma and/or cerebrospinal fluid (CSF) between patients with sporadic amyotrophic lateral sclerosis (SALS), familial ALS (FALS) showing the Leu126Ser mutation in the Cu, Zn-SOD gene and controls." | 3.73 | Oxidative stress and metal content in blood and cerebrospinal fluid of amyotrophic lateral sclerosis patients with and without a Cu, Zn-superoxide dismutase mutation. ( Hayabara, T; Ihara, Y; Nobukuni, K; Takata, H, 2005) |
" Based on this small study, L-serine appears to be generally safe for patients with ALS." | 2.84 | Phase I clinical trial of safety of L-serine for ALS patients. ( Banack, SA; Bradley, WG; Cox, PA; Flynn, LE; Forshew, DA; Katz, JS; Levine, TD; Metcalf, JS; Miller, RG; Moore, DH; Saperstein, DS, 2017) |
" Hyperphosphorylated TDP-43 was found within the inclusion bodies in disease lesions; however, the role of hyperphosphorylation and the toxic species are still ambiguous." | 1.72 | Hyperphosphorylation-Mimetic TDP-43 Drives Amyloid Formation and Possesses Neuronal Toxicity at the Oligomeric Stage. ( Chang, LY; Chen, YR; Chiang, WC; Chou, SC; Fang, YS; Ganesan, K; Huang, SH; Lye, YS; Weng, TY, 2022) |
" UHPLC-MS/MS was used to confirm BMAA exposures in dosed vervets." | 1.56 | l-Serine Reduces Spinal Cord Pathology in a Vervet Model of Preclinical ALS/MND. ( Banack, SA; Beierschmitt, A; Bradley, WG; Cox, PA; Davis, DA; Garamszegi, SP; Hagan, MJ; Lecusay, PD; Mash, DC; Metcalf, JS; Palmour, RM; Powell, JT, 2020) |
"Amyotrophic lateral sclerosis (ALS) is a devastating disease characterized by upper and lower motor neuron damage." | 1.36 | Familial amyotrophic lateral sclerosis with a novel G85S mutation of superoxide dismutase 1 gene: clinical features of lower motor neuron disease. ( Hirayama, T; Ikeda, K; Ito, H; Iwasaki, Y; Kano, O; Kawabe, K; Nakamura, Y; Sobue, G; Takazawa, T; Tanaka, F; Yoshii, Y, 2010) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (4.17) | 18.7374 |
1990's | 2 (4.17) | 18.2507 |
2000's | 16 (33.33) | 29.6817 |
2010's | 22 (45.83) | 24.3611 |
2020's | 6 (12.50) | 2.80 |
Authors | Studies |
---|---|
Lone, MA | 1 |
Aaltonen, MJ | 1 |
Zidell, A | 1 |
Pedro, HF | 1 |
Morales Saute, JA | 1 |
Mathew, S | 1 |
Mohassel, P | 1 |
Bönnemann, CG | 1 |
Shoubridge, EA | 1 |
Hornemann, T | 1 |
Chiang, WC | 1 |
Fang, YS | 1 |
Lye, YS | 1 |
Weng, TY | 1 |
Ganesan, K | 1 |
Huang, SH | 1 |
Chang, LY | 1 |
Chou, SC | 1 |
Chen, YR | 1 |
Di Maio, A | 1 |
Nuzzo, T | 1 |
Gilio, L | 1 |
Serra, M | 1 |
Buttari, F | 1 |
Errico, F | 1 |
De Rosa, A | 1 |
Bassi, MS | 1 |
Morelli, M | 1 |
Sasabe, J | 5 |
Sulzer, D | 1 |
Carta, M | 1 |
Centonze, D | 1 |
Usiello, A | 1 |
Ye, J | 1 |
Cheung, J | 1 |
Gerbino, V | 1 |
Ahlsén, G | 1 |
Zimanyi, C | 1 |
Hirsh, D | 1 |
Maniatis, T | 1 |
Davis, DA | 2 |
Cox, PA | 4 |
Banack, SA | 3 |
Lecusay, PD | 1 |
Garamszegi, SP | 1 |
Hagan, MJ | 1 |
Powell, JT | 1 |
Metcalf, JS | 3 |
Palmour, RM | 1 |
Beierschmitt, A | 1 |
Bradley, WG | 3 |
Mash, DC | 2 |
Chen, Q | 1 |
Konrad, C | 1 |
Sandhu, D | 1 |
Roychoudhury, D | 1 |
Schwartz, BI | 1 |
Cheng, RR | 1 |
Bredvik, K | 1 |
Kawamata, H | 1 |
Calder, EL | 1 |
Studer, L | 1 |
Fischer, SM | 1 |
Manfredi, G | 1 |
Gross, SS | 1 |
Padhi, AK | 1 |
Zhang, KYJ | 1 |
Miller, RX | 1 |
Levine, TD | 2 |
Stommel, EW | 1 |
Aliaga, L | 1 |
Lai, C | 1 |
Yu, J | 1 |
Chub, N | 1 |
Shim, H | 1 |
Sun, L | 1 |
Xie, C | 1 |
Yang, WJ | 1 |
Lin, X | 1 |
O'Donovan, MJ | 1 |
Cai, H | 1 |
Paul, P | 3 |
Murphy, T | 1 |
Oseni, Z | 1 |
Sivalokanathan, S | 1 |
de Belleroche, JS | 1 |
Bardaweel, SK | 1 |
Alzweiri, M | 1 |
Ishaqat, AA | 1 |
de Belleroche, J | 2 |
Abdelkarim, S | 1 |
Morgan, S | 1 |
Plagnol, V | 1 |
Lu, CH | 1 |
Adamson, G | 1 |
Howard, R | 1 |
Malaspina, A | 1 |
Orrell, R | 1 |
Sharma, N | 1 |
Sidle, K | 1 |
Clarke, J | 1 |
Fox, NC | 1 |
Rossor, MN | 1 |
Warren, JD | 1 |
Clark, CN | 1 |
Rohrer, JD | 1 |
Fisher, EM | 1 |
Mead, S | 1 |
Pittman, A | 1 |
Fratta, P | 1 |
Brenner, D | 1 |
Müller, K | 1 |
Wieland, T | 1 |
Weydt, P | 1 |
Böhm, S | 1 |
Lulé, D | 1 |
Hübers, A | 1 |
Neuwirth, C | 1 |
Weber, M | 1 |
Borck, G | 1 |
Wahlqvist, M | 1 |
Danzer, KM | 1 |
Volk, AE | 1 |
Meitinger, T | 1 |
Strom, TM | 1 |
Otto, M | 1 |
Kassubek, J | 1 |
Ludolph, AC | 1 |
Andersen, PM | 1 |
Weishaupt, JH | 1 |
Miller, RG | 1 |
Moore, DH | 1 |
Saperstein, DS | 1 |
Flynn, LE | 1 |
Katz, JS | 1 |
Forshew, DA | 1 |
Lin, H | 1 |
Hu, H | 1 |
Duan, W | 1 |
Liu, Y | 2 |
Tan, G | 1 |
Li, Z | 1 |
Deng, B | 1 |
Song, X | 1 |
Wang, W | 1 |
Wen, D | 1 |
Wang, Y | 1 |
Li, C | 1 |
Inukai, Y | 1 |
Nonaka, T | 2 |
Arai, T | 2 |
Yoshida, M | 1 |
Hashizume, Y | 1 |
Beach, TG | 1 |
Buratti, E | 1 |
Baralle, FE | 1 |
Akiyama, H | 3 |
Hisanaga, S | 1 |
Hasegawa, M | 2 |
Kametani, F | 1 |
Suzuki, T | 1 |
Dohmae, N | 1 |
Kadoyama, K | 1 |
Funakoshi, H | 1 |
Ohya-Shimada, W | 1 |
Nakamura, T | 2 |
Matsumoto, K | 1 |
Matsuyama, S | 1 |
Takazawa, T | 1 |
Ikeda, K | 1 |
Hirayama, T | 1 |
Kawabe, K | 1 |
Nakamura, Y | 1 |
Ito, H | 2 |
Kano, O | 1 |
Yoshii, Y | 1 |
Tanaka, F | 1 |
Sobue, G | 1 |
Iwasaki, Y | 1 |
Nozaki, I | 1 |
Arai, M | 1 |
Takahashi, K | 1 |
Hamaguchi, T | 1 |
Yoshikawa, H | 1 |
Muroishi, T | 1 |
Noguchi-Shinohara, M | 1 |
Itokawa, M | 1 |
Kawata, A | 1 |
Yamada, M | 2 |
Aiso, S | 5 |
Brotherton, T | 1 |
Polak, M | 1 |
Kelly, C | 1 |
Birve, A | 1 |
Andersen, P | 1 |
Marklund, SL | 1 |
Glass, JD | 1 |
Subramony, SH | 1 |
Ashizawa, T | 1 |
Langford, L | 1 |
McKenna, R | 1 |
Avvaru, B | 1 |
Siddique, T | 1 |
Vedanarayanan, V | 1 |
Thompson, M | 1 |
Marecki, JC | 1 |
Marinesco, S | 1 |
Labrie, V | 1 |
Roder, JC | 1 |
Barger, SW | 1 |
Crow, JP | 1 |
Miyoshi, Y | 2 |
Suzuki, M | 2 |
Mita, M | 1 |
Konno, R | 2 |
Matsuoka, M | 3 |
Hamase, K | 2 |
Yamanaka, M | 1 |
Ohide, H | 1 |
Satoi, H | 1 |
Tomimoto, H | 1 |
Ohtani, R | 1 |
Kitano, T | 1 |
Kondo, T | 1 |
Watanabe, M | 1 |
Oka, N | 1 |
Akiguchi, I | 1 |
Furuya, S | 1 |
Hirabayashi, Y | 1 |
Okazaki, T | 1 |
Battistini, S | 1 |
Giannini, F | 1 |
Greco, G | 1 |
Bibbò, G | 1 |
Ferrera, L | 1 |
Marini, V | 1 |
Causarano, R | 1 |
Casula, M | 1 |
Lando, G | 1 |
Patrosso, MC | 1 |
Caponnetto, C | 1 |
Origone, P | 1 |
Marocchi, A | 1 |
Del Corona, A | 1 |
Siciliano, G | 2 |
Carrera, P | 1 |
Mascia, V | 1 |
Giagheddu, M | 1 |
Carcassi, C | 1 |
Orrù, S | 1 |
Garrè, C | 1 |
Penco, S | 1 |
Ihara, Y | 1 |
Nobukuni, K | 1 |
Takata, H | 1 |
Hayabara, T | 1 |
Slowik, A | 1 |
Tomik, B | 1 |
Wolkow, PP | 1 |
Partyka, D | 1 |
Turaj, W | 1 |
Malecki, MT | 1 |
Pera, J | 1 |
Dziedzic, T | 1 |
Szczudlik, A | 1 |
Figlewicz, DA | 1 |
Kanekura, K | 1 |
Nishimoto, I | 2 |
Watanabe, S | 1 |
Nagano, S | 1 |
Duce, J | 1 |
Kiaei, M | 1 |
Li, QX | 1 |
Tucker, SM | 1 |
Tiwari, A | 1 |
Brown, RH | 1 |
Beal, MF | 1 |
Hayward, LJ | 1 |
Culotta, VC | 1 |
Yoshihara, S | 1 |
Sakoda, S | 1 |
Bush, AI | 1 |
Lobsiger, CS | 1 |
Boillée, S | 1 |
Cleveland, DW | 1 |
Coppedè, F | 1 |
Mancuso, M | 1 |
Lo Gerfo, A | 1 |
Carlesi, C | 1 |
Piazza, S | 1 |
Rocchi, A | 1 |
Petrozzi, L | 1 |
Nesti, C | 1 |
Micheli, D | 1 |
Bacci, A | 1 |
Migliore, L | 1 |
Murri, L | 1 |
Mitne-Neto, M | 1 |
Ramos, CR | 1 |
Pimenta, DC | 1 |
Luz, JS | 1 |
Nishimura, AL | 1 |
Gonzales, FA | 1 |
Oliveira, CC | 1 |
Zatz, M | 1 |
Morimoto, N | 1 |
Nagai, M | 1 |
Ohta, Y | 1 |
Miyazaki, K | 1 |
Kurata, T | 1 |
Morimoto, M | 1 |
Murakami, T | 1 |
Takehisa, Y | 1 |
Ikeda, Y | 1 |
Kamiya, T | 1 |
Abe, K | 1 |
Chiba, T | 1 |
Okamoto, K | 1 |
Irie, T | 1 |
Watanabe, T | 1 |
Mikami, H | 1 |
Yamazaki, T | 1 |
Oyanagi, K | 1 |
Ono, S | 1 |
Van Deerlin, VM | 1 |
Leverenz, JB | 1 |
Bekris, LM | 1 |
Bird, TD | 1 |
Yuan, W | 1 |
Elman, LB | 1 |
Clay, D | 1 |
Wood, EM | 1 |
Chen-Plotkin, AS | 1 |
Martinez-Lage, M | 1 |
Steinbart, E | 1 |
McCluskey, L | 1 |
Grossman, M | 1 |
Neumann, M | 1 |
Wu, IL | 1 |
Yang, WS | 1 |
Kalb, R | 1 |
Galasko, DR | 1 |
Montine, TJ | 1 |
Trojanowski, JQ | 2 |
Lee, VM | 2 |
Schellenberg, GD | 1 |
Yu, CE | 1 |
Rainero, I | 1 |
Pinessi, L | 1 |
Tsuda, T | 1 |
Vignocchi, MG | 1 |
Vaula, G | 1 |
Calvi, L | 1 |
Cerrato, P | 1 |
Rossi, B | 1 |
Bergamini, L | 1 |
McLachlan, DR | 1 |
Mawal-Dewan, M | 1 |
Schmidt, ML | 1 |
Balin, B | 1 |
Perl, DP | 1 |
Katunuma, N | 1 |
Yasogawa, N | 1 |
Kito, K | 1 |
Sanada, Y | 1 |
Kawai, H | 1 |
Miyoshi, K | 1 |
Pivovarova, VM | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Tolerability and Efficacy of L-Serine in Patients With Amyotrophic Lateral Sclerosis: A Phase IIa Study[NCT03580616] | Phase 2 | 43 participants (Actual) | Interventional | 2018-10-24 | Terminated (stopped due to Study was terminated by the IRB due to continued noncompliance.) | ||
Identification of Genes Causing Familial ALS or Increasing Risk for Sporadic ALS and ALS With Frontotemporal Dementia and Understanding Disease Mechanism.[NCT00821132] | 13,521 participants (Actual) | Observational | 1991-01-31 | Completed | |||
Amyotrophic Lateral Sclerosis and the Innate Immune System[NCT02869048] | 375 participants (Anticipated) | Observational | 2016-06-30 | Recruiting | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
6 reviews available for serine and ALS - Amyotrophic Lateral Sclerosis
Article | Year |
---|---|
D-Serine in neurobiology: CNS neurotransmission and neuromodulation.
Topics: Alzheimer Disease; Amyotrophic Lateral Sclerosis; Animals; Central Nervous System; Epilepsy; Glutami | 2014 |
Experimental approaches for elucidating co-agonist regulation of NMDA receptor in motor neurons: Therapeutic implications for amyotrophic lateral sclerosis (ALS).
Topics: Amyotrophic Lateral Sclerosis; Animals; D-Amino-Acid Oxidase; Excitatory Amino Acid Agonists; Humans | 2015 |
Aberrant control of motoneuronal excitability in amyotrophic lateral sclerosis: excitatory glutamate/D-serine vs. inhibitory glycine/gamma-aminobutanoic acid (GABA).
Topics: Amyotrophic Lateral Sclerosis; Excitatory Amino Acids; gamma-Aminobutyric Acid; Glutamic Acid; Glyci | 2010 |
[D-serine in the pathogenesis of amyotrophic lateral sclerosis].
Topics: Amyotrophic Lateral Sclerosis; Animals; Cell Death; Humans; Mice; Neurons; Receptors, N-Methyl-D-Asp | 2010 |
The role of D-amino acids in amyotrophic lateral sclerosis pathogenesis: a review.
Topics: Amyotrophic Lateral Sclerosis; Animals; Brain; D-Amino-Acid Oxidase; Disease Progression; Gene Expre | 2012 |
D-Amino acids in the brain and mutant rodents lacking D-amino-acid oxidase activity.
Topics: Amyotrophic Lateral Sclerosis; Animals; Behavior, Animal; Brain; D-Amino-Acid Oxidase; D-Aspartic Ac | 2012 |
2 trials available for serine and ALS - Amyotrophic Lateral Sclerosis
Article | Year |
---|---|
Studies of Environmental Risk Factors in Amyotrophic Lateral Sclerosis (ALS) and a Phase I Clinical Trial of L-Serine.
Topics: Amyotrophic Lateral Sclerosis; Environmental Exposure; Female; Humans; Male; Middle Aged; Neuroprote | 2018 |
Phase I clinical trial of safety of L-serine for ALS patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amyotrophic Lateral Sclerosis; Disease Progression; Dose | 2017 |
40 other studies available for serine and ALS - Amyotrophic Lateral Sclerosis
Article | Year |
---|---|
SPTLC1 variants associated with ALS produce distinct sphingolipid signatures through impaired interaction with ORMDL proteins.
Topics: Amyotrophic Lateral Sclerosis; Hereditary Sensory and Autonomic Neuropathies; Humans; Membrane Prote | 2022 |
Hyperphosphorylation-Mimetic TDP-43 Drives Amyloid Formation and Possesses Neuronal Toxicity at the Oligomeric Stage.
Topics: Amyloid; Amyloidogenic Proteins; Amyloidosis; Amyotrophic Lateral Sclerosis; DNA-Binding Proteins; H | 2022 |
Homeostasis of serine enantiomers is disrupted in the post-mortem caudate putamen and cerebrospinal fluid of living Parkinson's disease patients.
Topics: Alzheimer Disease; Amino Acids; Amyotrophic Lateral Sclerosis; Homeostasis; Humans; N-Methylaspartat | 2023 |
Effects of ALS-associated TANK binding kinase 1 mutations on protein-protein interactions and kinase activity.
Topics: Amyotrophic Lateral Sclerosis; Cell Cycle Proteins; Enzyme Activation; Humans; Membrane Transport Pr | 2019 |
l-Serine Reduces Spinal Cord Pathology in a Vervet Model of Preclinical ALS/MND.
Topics: Amino Acids, Diamino; Amyotrophic Lateral Sclerosis; Animals; Chlorocebus aethiops; Cyanobacteria To | 2020 |
Accelerated transsulfuration metabolically defines a discrete subclass of amyotrophic lateral sclerosis patients.
Topics: Aged; Amyotrophic Lateral Sclerosis; Case-Control Studies; Cells, Cultured; Cysteine; Female; Fibrob | 2020 |
Mechanistic insights into the loss-of-function mechanisms of rare human D-amino acid oxidase variants implicated in amyotrophic lateral sclerosis.
Topics: Amyotrophic Lateral Sclerosis; Crystallography, X-Ray; D-Amino-Acid Oxidase; Flavin-Adenine Dinucleo | 2020 |
Amyotrophic lateral sclerosis-related VAPB P56S mutation differentially affects the function and survival of corticospinal and spinal motor neurons.
Topics: Amino Acid Substitution; Amyotrophic Lateral Sclerosis; Animals; Cell Survival; Dendrites; Humans; M | 2013 |
Pathogenic effects of amyotrophic lateral sclerosis-linked mutation in D-amino acid oxidase are mediated by D-serine.
Topics: Amyotrophic Lateral Sclerosis; Animals; Apoptosis; Astrocytes; Autophagy; Cells, Cultured; D-Amino-A | 2014 |
CHCHD10 Pro34Ser is not a highly penetrant pathogenic variant for amyotrophic lateral sclerosis and frontotemporal dementia.
Topics: Amyotrophic Lateral Sclerosis; Cohort Studies; Frontotemporal Dementia; Genetic Variation; Humans; M | 2016 |
Dietary exposure to an environmental toxin triggers neurofibrillary tangles and amyloid deposits in the brain.
Topics: Amino Acids, Diamino; Amyloid beta-Peptides; Amyotrophic Lateral Sclerosis; Animals; Brain; Chloroce | 2016 |
NEK1 mutations in familial amyotrophic lateral sclerosis.
Topics: Adult; Aged; Amyotrophic Lateral Sclerosis; Brain; Cohort Studies; Family Health; Female; Gene Frequ | 2016 |
ALSUntangled 38: L-serine.
Topics: Amyotrophic Lateral Sclerosis; Clinical Trials as Topic; Humans; Risk; Serine; Treatment Outcome | 2017 |
Intramuscular Delivery of scAAV9-hIGF1 Prolongs Survival in the hSOD1
Topics: Amyotrophic Lateral Sclerosis; Animals; Apoptosis; D-Amino-Acid Oxidase; Dependovirus; Disease Model | 2018 |
Abnormal phosphorylation of Ser409/410 of TDP-43 in FTLD-U and ALS.
Topics: Amyotrophic Lateral Sclerosis; Animals; Antibodies, Monoclonal; Brain; Dementia; DNA-Binding Protein | 2008 |
Identification of casein kinase-1 phosphorylation sites on TDP-43.
Topics: Amino Acid Sequence; Amyotrophic Lateral Sclerosis; Brain; Casein Kinase I; Dementia; DNA-Binding Pr | 2009 |
Disease-dependent reciprocal phosphorylation of serine and tyrosine residues of c-Met/HGF receptor contributes disease retardation of a transgenic mouse model of ALS.
Topics: Amino Acid Sequence; Amyotrophic Lateral Sclerosis; Animals; Catalytic Domain; Central Nervous Syste | 2009 |
Familial amyotrophic lateral sclerosis with a novel G85S mutation of superoxide dismutase 1 gene: clinical features of lower motor neuron disease.
Topics: Adult; Amyotrophic Lateral Sclerosis; Fatal Outcome; Female; Glycine; Humans; Male; Motor Neuron Dis | 2010 |
Familial ALS with G298S mutation in TARDBP: a comparison of CSF tau protein levels with those in sporadic ALS.
Topics: Amino Acid Substitution; Amyotrophic Lateral Sclerosis; DNA-Binding Proteins; Glycine; Humans; Male; | 2010 |
A novel ALS SOD1 C6S mutation with implications for aggregation related toxicity and genetic counseling.
Topics: Adult; Aged; Amyotrophic Lateral Sclerosis; Cysteine; Disulfides; DNA Mutational Analysis; Female; G | 2011 |
Confirmation of the severe phenotypic effect of serine at codon 41 of the superoxide dismutase 1 gene.
Topics: Adult; Amyotrophic Lateral Sclerosis; Family Health; Female; Glycine; Humans; Male; Middle Aged; Mod | 2011 |
Paradoxical roles of serine racemase and D-serine in the G93A mSOD1 mouse model of amyotrophic lateral sclerosis.
Topics: Amyotrophic Lateral Sclerosis; Animals; Disease Models, Animal; Disease Progression; Female; Humans; | 2012 |
D-amino acid oxidase controls motoneuron degeneration through D-serine.
Topics: Amyotrophic Lateral Sclerosis; Animals; Astrocytes; Blotting, Western; Cell Death; Chromatography, H | 2012 |
Astroglial expression of ceramide in Alzheimer's disease brains: a role during neuronal apoptosis.
Topics: Aged; Alzheimer Disease; Amyotrophic Lateral Sclerosis; Animals; Apoptosis; Astrocytes; Cell Line, T | 2005 |
SOD1 mutations in amyotrophic lateral sclerosis. Results from a multicenter Italian study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amyotrophic Lateral Sclerosis; Blotting, Northern; Cohor | 2005 |
Oxidative stress and metal content in blood and cerebrospinal fluid of amyotrophic lateral sclerosis patients with and without a Cu, Zn-superoxide dismutase mutation.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Aged; Amyotrophic Lateral Sclerosis; Case-Control Studies; Deoxyguanosi | 2005 |
Paraoxonase gene polymorphisms and sporadic ALS.
Topics: Adult; Aged; Amyotrophic Lateral Sclerosis; Arginine; Aryldialkylphosphatase; Chi-Square Distributio | 2006 |
Characterization of amyotrophic lateral sclerosis-linked P56S mutation of vesicle-associated membrane protein-associated protein B (VAPB/ALS8).
Topics: Amino Acid Substitution; Amyotrophic Lateral Sclerosis; Animals; Cell Line, Tumor; Endoplasmic Retic | 2006 |
Increased affinity for copper mediated by cysteine 111 in forms of mutant superoxide dismutase 1 linked to amyotrophic lateral sclerosis.
Topics: Amino Acid Substitution; Amyotrophic Lateral Sclerosis; Animals; Chlorocebus aethiops; Chromatograph | 2007 |
Toxicity from different SOD1 mutants dysregulates the complement system and the neuronal regenerative response in ALS motor neurons.
Topics: Aging; Amyotrophic Lateral Sclerosis; Animals; Animals, Genetically Modified; Cell Separation; Enzym | 2007 |
Association of the hOGG1 Ser326Cys polymorphism with sporadic amyotrophic lateral sclerosis.
Topics: Age Factors; Aged; Amino Acid Sequence; Amino Acid Substitution; Amyotrophic Lateral Sclerosis; Cyst | 2007 |
A mutation in human VAP-B--MSP domain, present in ALS patients, affects the interaction with other cellular proteins.
Topics: Amino Acid Substitution; Amyotrophic Lateral Sclerosis; Cloning, Molecular; Escherichia coli; Glycer | 2007 |
Increased autophagy in transgenic mice with a G93A mutant SOD1 gene.
Topics: Amyotrophic Lateral Sclerosis; Animals; Autophagy; Central Nervous System; Disease Models, Animal; F | 2007 |
D-serine is a key determinant of glutamate toxicity in amyotrophic lateral sclerosis.
Topics: Amyotrophic Lateral Sclerosis; Animals; Disease Models, Animal; Enzyme Activation; Enzyme Induction; | 2007 |
Familial amyotrophic lateral sclerosis with Gly93Ser mutation in Cu/Zn superoxide dismutase: a clinical and neuropathological study.
Topics: Adult; Amyotrophic Lateral Sclerosis; Central Nervous System; Family Health; Female; Glycine; Humans | 2008 |
TARDBP mutations in amyotrophic lateral sclerosis with TDP-43 neuropathology: a genetic and histopathological analysis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alanine; Amyotrophic Lateral Sclerosis; Brain; Child; De | 2008 |
SOD1 missense mutation in an Italian family with ALS.
Topics: Adult; Amyotrophic Lateral Sclerosis; Base Sequence; Chromosomes, Human, Pair 21; DNA; DNA Primers; | 1994 |
Identification of phosphorylation sites in PHF-TAU from patients with Guam amyotrophic lateral sclerosis/parkinsonism-dementia complex.
Topics: Aged; Amyotrophic Lateral Sclerosis; Binding Sites, Antibody; Blotting, Western; Brain Chemistry; De | 1996 |
Abnormal expression of a serine protease in human dystrophic muscle.
Topics: Adult; Aged; Amyotrophic Lateral Sclerosis; Child; Child, Preschool; Endopeptidases; Humans; L-Lacta | 1978 |
[Amino acid metabolism in lateral amyotrophic sclerosis].
Topics: Adult; Aged; Amino Acids; Amyotrophic Lateral Sclerosis; Arginine; Female; Humans; Leucine; Male; Mi | 1971 |